Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction

Journal of Proteomics

Volumn 103, Issue , 2014, Pages 204-215

  Musrap, Natasha ^a,b   Karagiannis, George S ^a,b   Saraon, Punit ^a,b   Batruch, Ihor ^b   Smith, Chris ^c   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Co culture; Metastasis; Mucin 5AC; Ovarian cancer; Peritoneum; Proteomics

Indexed keywords

MESSENGER RNA; MUCIN 5AC; PROTEIN; PROTEOME; CULTURE MEDIUM; TUMOR PROTEIN;

ARTICLE; ASCITES FLUID; CANCER CELL; CANCER CELL CULTURE; CELL CONTACT; CELL INTERACTION; CELL MIGRATION ASSAY; COCULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESOTHELIUM CELL; MONOCULTURE; OVARY CANCER; PERITONEUM CELL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; CHEMISTRY; CULTURE MEDIUM; EPITHELIUM; EPITHELIUM CELL; METABOLISM; OVARY TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM TUMOR; PHARMACOLOGY; PROCEDURES; SECONDARY; SECRETION (PROCESS); TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; MUCIN 5AC; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROTEOMICS;

EID: 84899873500     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.03.042     Document Type: Article

References (49)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Pignata S., Cannella L., Leopardo D., Pisano C., Bruni G.S., Facchini G. Chemotherapy in epithelial ovarian cancer. Cancer Lett 2011, 303:73-83.
3. Vaughan S., Coward J.I., Bast R.C., Berchuck A., Berek J.S., Brenton J.D., et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 2011, 11:719-725.
4. Puiffe M.L., Le Page C., Filali-Mouhim A., Zietarska M., Ouellet V., Tonin P.N., et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 2007, 9:820-829.
5. Meunier L., Puiffe M.L., Le Page C., Filali-Mouhim A., Chevrette M., Tonin P.N., et al. Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model. Transl Oncol 2010, 3:230-238.
6. Cai J., Tang H., Xu L., Wang X., Yang C., Ruan S., et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 2012, 33:20-29.
7. Musrap N., Diamandis E.P. Revisiting the complexity of the ovarian cancer microenvironment-clinical implications for treatment strategies. Mol Cancer Res 2012, 10:1254-1264.
8. Ren J., Xiao Y.J., Singh L.S., Zhao X., Zhao Z., Feng L., et al. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 2006, 66:3006-3014.
9. Cannistra S.A., Kansas G.S., Niloff J., DeFranzo B., Kim Y., Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993, 53:3830-3838.
10. Gardner M.J., Jones L.M., Catterall J.B., Turner G.A. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 1995, 91:229-234.
11. Lessan K., Aguiar D.J., Oegema T., Siebenson L., Skubitz A.P. CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 1999, 154:1525-1537.
12. Niedbala M.J., Crickard K., Bernacki R.J. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res 1985, 160:499-513.
13. Rieppi M., Vergani V., Gatto C., Zanetta G., Allavena P., Taraboletti G., et al. Mesothelial cells induce the motility of human ovarian carcinoma cells. Int J Cancer 1999, 80:303-307.
14. Strobel T., Cannistra S.A. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 1999, 73:362-367.
15. Slack-Davis J.K., Atkins K.A., Harrer C., Hershey E.D., Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 2009, 69:1469-1476.
16. Tzuman Y.C., Sapoznik S., Granot D., Nevo N., Neeman M. Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins. Neoplasia 2010, 12:51-60.
17. Karagiannis G.S., Petraki C., Prassas I., Saraon P., Musrap N., Dimitromanolakis A., et al. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 2012, 3:267-285.
18. Ween M.P., Lokman N.A., Hoffmann P., Rodgers R.J., Ricciardelli C., Oehler M.K. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer 2011, 128:1570-1584.
19. Tien C.L., Lin C.H., Lin T.H., Wen F.C., Su C.W., Fan S.S., et al. Secreted cyclophilin A induction during embryo implantation in a model of human trophoblast-endometrial epithelium interaction. Eur J Obstet Gynecol Reprod Biol 2012, 164:55-59.
20. Zeng X., Yang P., Chen B., Jin X., Liu Y., Zhao X., et al. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. J Proteomics 2013, 89:51-70.
21. Garcion C., Baltensperger R., Fournier T., Pasquier J., Schnetzer M.A., Gabriel J.P., et al. FiRe and microarrays: a fast answer to burning questions. Trends Plant Sci 2006, 11:320-322.
22. Ahmed A.A., Etemadmoghadam D., Temple J., Lynch A.G., Riad M., Sharma R., et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 2010, 221:49-56.
23. Kulbe H., Thompson R., Wilson J.L., Robinson S., Hagemann T., Fatah R., et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007, 67:585-592.
24. Doherty J.A., Rossing M.A., Cushing-Haugen K.L., Chen C., Van Den Berg D.J., Wu A.H., et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev 2010, 19:245-250.
25. Ziprin P., Ridgway P.F., Pfistermuller K.L., Peck D.H., Darzi A.W. ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 2003, 10:141-154.
26. Kim M., Rooper L., Xie J., Kajdacsy-Balla A.A., Barbolina M.V. Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Mol Cancer Res 2012, 10:11-24.
27. Burleson K.M., Casey R.C., Skubitz K.M., Pambuccian S.E., Oegema T.R., Skubitz A.P. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 2004, 93:170-181.
28. Yoffou P.H., Edjekouane L., Meunier L., Tremblay A., Provencher D.M., Mes-Masson A.M., et al. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer. PLoS One 2011, 6:e20705.
29. Andersen J.D., Boylan K.L., Jemmerson R., Geller M.A., Misemer B., Harrington K.M., et al. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J Ovarian Res 2010, 3:21.
30. Zhang Q., Hu G., Yang Q., Dong R., Xie X., Ma D., et al. A multiplex methylation specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA. Gynecol Oncol 2013, 130:132-139.
31. Ji H., Isacson C., Seidman J.D., Kurman R.J., Ronnett B.M. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002, 21:391-400.
32. Haslene-Hox H., Oveland E., Woie K., Salvesen H.B., Wiig H., Tenstad O. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue. Biochim Biophys Acta 1834, 2013:2347-2359.
33. Lau S.K., Weiss L.M., Chu P.G. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004, 122:61-69.
34. Han L., Pansare V., Al-Abbadi M., Husain M., Feng J. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. Diagn Cytopathol 2009, 38:333-336.
35. Kufe D.W. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009, 9:874-885.
36. Kobayashi E., Ueda Y., Matsuzaki S., Yokoyama T., Kimura T., Yoshino K., et al. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2012, 21:1902-1912.
37. Kaneko O., Gong L., Zhang J., Hansen J.K., Hassan R., Lee B., et al. A binding domain on mesothelin for CA125/MUC16. J Biol Chem 2009, 284:3739-3749.
38. Chauhan S.C., Singh A.P., Ruiz F., Johansson S.L., Jain M., Smith L.M., et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006, 19:1386-1394.
39. Ponnusamy M.P., Singh A.P., Jain M., Chakraborty S., Moniaux N., Batra S.K. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer 2008, 99:520-526.
40. Ponnusamy M.P., Lakshmanan I., Jain M., Das S., Chakraborty S., Dey P., et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010, 29:5741-5754.
41. Yamazoe S., Tanaka H., Sawada T., Amano R., Yamada N., Ohira M., et al. RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells. J Exp Clin Cancer Res 2010, 29:53.
42. Hoshi H., Sawada T., Uchida M., Saito H., Iijima H., Toda-Agetsuma M., et al. Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer. Int J Oncol 2011, 38:619-627.
43. Hoshi H., Sawada T., Uchida M., Iijima H., Kimura K., Hirakawa K., et al. MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways. Int J Oncol 2013, 42:887-893.
44. Fujisawa T., Velichko S., Thai P., Hung L.Y., Huang F., Wu R. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol 2009, 183:6236-6243.
45. Song K.S., Lee W.J., Chung K.C., Koo J.S., Yang E.J., Choi J.Y., et al. Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem 2003, 278:23243-23250.
46. Mochizuki Y., Nakanishi H., Kodera Y., Ito S., Yamamura Y., Kato T., et al. TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 2004, 21:39-47.
47. Hernandez L., Hsu S.C., Davidson B., Birrer M.J., Kohn E.C., Annunziata C.M. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res 2010, 70:4005-4014.
48. van Grevenstein W.M., Hofland L.J., van Rossen M.E., van Koetsveld P.M., Jeekel J., van Eijck C.H. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci 2007, 52:2775-2783.
49. Stadlmann S., Raffeiner R., Amberger A., Margreiter R., Zeimet A.G., Abendstein B., et al. Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha. Virchows Arch 2003, 443:678-685.